BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 AUD
0,00%
(0,00) 1D
18-ноя., 16:10:16 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
22,10 млн
Avg. vol.
10,87 млн
Volume
29,97 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
22,10 млн
Avg. vol.
10,87 млн
Volume
29,97 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
News stories
From web sources and news partners
Investopedia
·
37 мүнөт мурун
Stock Market Today: Nasdaq, S&P 500 Futures Rise as Nvidia Shares Jump After Strong Earnings Report; Anthropic IPO on Deck
The Motley Fool
·
14 мүнөт мурун
Why S&P 500 ETF Investors Don't Have to Worry (Much) About Nvidia Stock Plunging
FinanceFeeds
·
16 мүнөт мурун
Nasdaq Composite After Nvidia Beat, Fed Minutes Next
FOREX.com
·
1 саат мурун
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com